Sep 29, 2016 8:30 am EDT iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd
Jul 5, 2016 8:31 am EDT iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate
Jun 29, 2016 8:31 am EDT iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis
Jun 7, 2016 8:31 am EDT Texas A&M University System and iBio Execute Joint Development Agreement for Plant-Produced Pharmaceuticals
Jan 14, 2016 9:00 am EST iBio Forms Joint Venture CMO for Large-Scale Pharmaceuticals Manufacturing in Green Plants and Accepts Additional Investment